LY3405105

CAS No. 2326428-25-3

LY3405105 ( —— )

Catalog No. M24064 CAS No. 2326428-25-3

1-Piperidinecarboxylic acid, 4-[[5-methyl-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]-, 1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]-3-pyrrolidinyl ester is a novel CDK7 inhibitors.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 57 In Stock
5MG 88 In Stock
10MG 146 In Stock
25MG 286 In Stock
50MG 428 In Stock
100MG 610 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    LY3405105
  • Note
    Research use only, not for human use.
  • Brief Description
    1-Piperidinecarboxylic acid, 4-[[5-methyl-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]-, 1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]-3-pyrrolidinyl ester is a novel CDK7 inhibitors.
  • Description
    1-Piperidinecarboxylic acid, 4-[[5-methyl-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]-, 1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]-3-pyrrolidinyl ester is a novel CDK7 inhibitors.
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    CDK7
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2326428-25-3
  • Formula Weight
    497.6
  • Molecular Formula
    C26H39N7O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    O=C(N1CCC(NC2=CC(C)=NC3=C(C(C)C)C=NN23)CC1)OC4CN(C(/C=C/CN(C)C)=O)CC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.David Andrew Coates, Carlos montero, bhavin Kumar Rameschandra Patel, et al. Compounds useful for inhibiting cdk7. US 20190144456A1.
molnova catalog
related products
  • ISOPIMPINELLIN

    Antiviral, anti HIV.

  • MLS-573151

    MLS-573151 is a selective inhibitor of GTPase Cdc42(EC50 of 2 μM).

  • NU-6102

    A potent CDK1 and CDK2 inhibitor with IC50 of 9.5 nM and 5.4 nM against CDK1/cyclinB and CDK2/cyclinA3 respectively.